Dorman Followwill

Insider Reports History

Location
San Diego, CA
Signature
/s/ Stephen Ma, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dorman Followwill:

Company Role Class Num Shares Value Price $ Report Date Ownership
Scilex Holding Co Director Common Stock 2,300 $2,277 $0.9900 18 Oct 2024 Direct
Sorrento Therapeutics, Inc. Director Stock option (right to buy) 250,000 30 Aug 2021 Direct
Scilex Holding Co Director Nonstatutory Stock Option (right to buy) 20,000 08 Oct 2025 Direct

Insider Reports Filed by Dorman Followwill

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SCLX Scilex Holding Co 08 Oct 2025 1 $0 4 Director 09 Oct 2025, 08:40
DNQAF Denali Capital Acquisition Corp. 22 Sep 2025 0 $0 3 Director 23 Sep 2025, 19:51
SCLX Scilex Holding Co 16 Dec 2024 1 $0 4 Director 17 Dec 2024, 17:15
SCLX Scilex Holding Co 18 Oct 2024 1 +$990 4 Director 18 Oct 2024, 16:29
SCLX Scilex Holding Co 26 Jun 2024 2 +$1,370 4 Director 26 Jun 2024, 21:31
SCLX Scilex Holding Co 15 Mar 2024 1 $0 4 Director 26 Jun 2024, 21:27
SCLX Scilex Holding Co 17 Jan 2023 1 $0 4 Director 17 Jan 2023, 16:36
SCLX Vickers Vantage Corp. I 10 Nov 2022 0 $0 3 Director 15 Nov 2022, 17:25
/report/000120919121053981-followwill-dorman-2021-08-30 Sorrento Therapeutics, Inc. 30 Aug 2021 1 $0 4 Director 30 Aug 2021, 20:12